These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2228312)

  • 1. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Rejthar A; Kovarík J; Lane DP
    Int J Cancer; 1990 Nov; 46(5):839-44. PubMed ID: 2228312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.
    McCann AH; Kirley A; Carney DN; Corbally N; Magee HM; Keating G; Dervan PA
    Br J Cancer; 1995 May; 71(5):981-5. PubMed ID: 7734324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.
    Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU
    Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
    Lisboa BW; Vogtländer S; Gilster T; Riethdorf L; Milde-Langosch K; Löning T
    Virchows Arch; 1997 Dec; 431(6):375-81. PubMed ID: 9428925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression.
    Liu XL; Band H; Gao Q; Wazer DE; Chu Q; Band V
    Carcinogenesis; 1994 Sep; 15(9):1969-73. PubMed ID: 7923592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.
    Balogh GA; Mailo DA; Corte MM; Roncoroni P; Nardi H; Vincent E; Martinez D; Cafasso ME; Frizza A; Ponce G; Vincent E; Barutta E; Lizarraga P; Lizarraga G; Monti C; Paolillo E; Vincent R; Quatroquio R; Grimi C; Maturi H; Aimale M; Spinsanti C; Montero H; Santiago J; Shulman L; Rivadulla M; Machiavelli M; Salum G; Cuevas MA; Picolini J; Gentili A; Gentili R; Mordoh J
    Int J Oncol; 2006 Apr; 28(4):995-1002. PubMed ID: 16525651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of calcium-binding protein S100A2 in breast lesions.
    Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
    Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
    Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of p53 alterations throughout breast cancer progression.
    Davidoff AM; Kerns BJ; Iglehart JD; Marks JR
    Cancer Res; 1991 May; 51(10):2605-10. PubMed ID: 1850660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.
    Cance WG; Harris JE; Iacocca MV; Roche E; Yang X; Chang J; Simkins S; Xu L
    Clin Cancer Res; 2000 Jun; 6(6):2417-23. PubMed ID: 10873094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
    Meenakshi A; Manoharan V
    Hum Antibodies; 1999; 9(3):171-6. PubMed ID: 10690631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
    Barton CM; Staddon SL; Hughes CM; Hall PA; O'Sullivan C; Klöppel G; Theis B; Russell RC; Neoptolemos J; Williamson RC
    Br J Cancer; 1991 Dec; 64(6):1076-82. PubMed ID: 1764370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
    Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
    J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nm23 protein expression in ductal in situ and invasive human breast carcinoma.
    Royds JA; Stephenson TJ; Rees RC; Shorthouse AJ; Silcocks PB
    J Natl Cancer Inst; 1993 May; 85(9):727-31. PubMed ID: 8386774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum p53 autoantibodies and characteristics of human breast cancer.
    Mudenda B; Green JA; Green B; Jenkins JR; Robertson L; Tarunina M; Leinster SJ
    Br J Cancer; 1994 Jun; 69(6):1115-9. PubMed ID: 8198980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
    Porter PL; Gown AM; Kramp SG; Coltrera MD
    Am J Pathol; 1992 Jan; 140(1):145-53. PubMed ID: 1731521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
    Zhu XL; Hartwick W; Rohan T; Kandel R
    Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.